| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 2 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| TDP1 protein | 7 | 0 | 0 | 7 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
| AR protein | 5 | 0 | 0 | 5 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
| progesterone receptor | 5 | 0 | 0 | 5 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
| estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
| estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
| G | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
| polyprotein | 3 | 0 | 0 | 3 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 4 | 0 | 0 | 4 |
| peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| geminin | 8 | 0 | 0 | 8 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Interferon beta | 4 | 0 | 0 | 4 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 6 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| D(2) dopamine receptor | 0 | 4 | 2 | 8 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
| D | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 3 | 0 | 4 |
| D(4) dopamine receptor | 0 | 3 | 1 | 6 |
| D(1B) dopamine receptor | 0 | 3 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 8 | 0 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 8 | 0 | 8 |
| D(4) dopamine receptor | 0 | 5 | 0 | 5 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 12 | 3 | 15 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 3 | 2 | 7 |
| 5-hydroxytryptamine receptor 2B | 0 | 5 | 0 | 5 |
| Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| D(2) dopamine receptor | 0 | 6 | 0 | 6 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 10 | 0 | 10 |
| 5-hydroxytryptamine receptor 3D | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 2 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
| IDH1 | 2 | 0 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 10 | 2 | 12 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 1 | 0 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
| GABA theta subunit | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
| aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| caspase-3 | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| caspase-3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 6 | 0 | 6 |
| Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 6 | 0 | 6 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
| Angiotensin-converting enzyme | 0 | 5 | 0 | 5 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
| Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 3 | 1 | 0 | 4 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 8 | 2 | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 7 | 0 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| Transporter | 0 | 3 | 0 | 3 |
| GLS protein | 2 | 0 | 0 | 2 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 1 | 0 | 0 | 1 |
| survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| D(1B) dopamine receptor | 0 | 4 | 0 | 4 |
| Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 1 | 4 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 3 | 9 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
| Histamine H2 receptor | 1 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 2 | 0 | 2 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Delta-type opioid receptor | 0 | 2 | 2 | 6 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 6 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
| Smad3 | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Envelope glycoprotein | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |